Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Cosmetic Factory won Best Technology Application 2025. EcoMundo’s AI-powered PLM helps cosmetic brands develop faster, safer, fully compliant products worldwide.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the importance of regulatory and environmental due diligence in M&A transactions. Discover how EcoMundo's experts ensure compliance with international regulations for sustainable business practices. Find out why due diligence now extends beyond financial audits to include EHS standards.
Discover the challenges of importing Korean beauty products to Europe, including compliance with EU regulations. Learn about new ingredients, post-Covid trends, and the importance of natural claims.
New UK REACH timetable extends registration deadlines up to 6 years. Companies must submit first notification by 30th April 2021. A solution to European companies that face complexities in appointing Only Representatives.
Learn about the reporting requirements for poison centres under Annex VIII of the CLP Regulation. Find out who is affected, the UFI code, notification deadlines, and how to comply with the new obligations. Stay informed and prepare now for upcoming deadlines.
A study by ECHA reveals that most European companies are substituting harmful substances, driven by regulatory measures like REACH restrictions and authorisations. Consumer demand, corporate image, and sustainability policies also significantly influence this shift towards greener alternatives.
The new Medical Devices Regulation (EU Regulation 2017/745) has been postponed to May 2021 due to Covid-19. Changes in classification rules and broader scope will impact businesses. Borderline products require vigilance, and all medical devices must be re-certified by 2024.